The Just – Evotec Biologics project in Toulouse reaches its conclusion
CAP INGELEC has successfully completed a major project for Just – Evotec Biologics: the turnkey construction of the J.POD® plant in Toulouse.
As part of its expansion, Just – Evotec Biologics has chosen to build its first European biotherapeutics plant, called J.POD®, in Toulouse. This plant, the second of its kind and the first in Europe, uses adaptable J.POD® technology to provide essential capabilities for the manufacture of clinical and commercial biologics.
As general contractor, CAP INGELEC played a key role in the completion of this major project. In less than 2 years, our teams designed and built 3,950 m² of turnkey cGMP cleanrooms. This project, completed to a very tight deadline, required close collaboration between all the parties involved.
Thanks to our expertise in building complex infrastructures for the pharmaceutical industry, we were able to meet these technical challenges in record time.
The inauguration of the J.POD® plant on the Curie Campus in Toulouse on 20 September was attended by a large number of VIPs, including the general management of Evotec and Just-Evotec Biologics, as well as local councillors. Matthieu Calès, Jean-Philippe Cottel and Mickaël Genty also took part in the ceremony to mark the successful completion of the project, and expressed their gratitude for the trust placed in them by Just-Evotec Biologics throughout the project.
🎬 Watch the video presentation of the project
🎬 Watch the interview with Mickaël Genty
